Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026
Syndax Pharmaceuticals announced it will host an R&D Day on July 14, 2026, at 8:30 AM ET in New York City. The event will feature presentations by management and key opinion leaders highlighting late-stage programs revumenib and axatilimab, as well as early-stage assets.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.